Examination Report |
1 | TM-1 | 30 Nov 2010 |
2 | TM-5 | 24 Apr 2012 |
3 | TM-16 | 16 Aug 2016 |
4 | Evidence Affidavit Under Rule 46 (TOP) | 13 May 2023 |
5 | Annexure -1 under rule 46 | 13 May 2023 |
6 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 20 Feb 2024 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 08 Apr 2024 |
1 | Hearing Notice | 14434793 | 5787307 | 05 Dec 2022 |
2 | Hearing Notice | 17085119 | 6446370 | 09 Jan 2024 |
3 | Hearing Notice | 17661690 | 6617433 | 08 Mar 2024 |
4 | Hearing Notice | 19022335 | 6945643 | 18 Oct 2024 |
As per IP India data the trademark was applied on 30 November 2010.
EMCURE PHARMACEUTICALS applied for Glycebet.
Listed class of trademark Glycebet is 5.
Glycebet is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 2061559
Trademark application was filed by the following attorney agent:
Aditya & Associates
The trademark is categorized as WORD.